News

Intellipharmaceutics, Par, Novartis Pharmaceuticals, Novartis Pharma, Celgene, Elan and Elan Pharma, have also entered into license agreements in conjunction with the settlements of the litigation concerning the company’s

Pharmacokinetic data from the initial Phase I trial of BNC210 reported on March 3, 2010 indicated that a plateau of absorption of BNC210 was observed at doses between

With this solution, pharmaceutical, biopharmaceutical and medical device / equipment companies can partner with their contract manufacturers (CMOs) and packagers (CPOs) to create a common view of production

Oramed Pharmaceuticals said that the randomised, double-blind, placebo-controlled, multi-centered study conducted in South Africa evaluated responses of 29 type 2 diabetes patients to ORMD-0801. Insulin-loaded or placebo capsules

Ondansetron hydrochloride is the active ingredient in Zofran, GlaxoSmithKline’s drug to prevent chemotherapy and radiation related nausea and vomiting. As per the terms of the licensing agreement, RedHill

Exco InTouch said that the webinar, in collaboration with Novartis, discussed distinct advantages of ePRO (electronic reported outcomes) using cellphone technology, known in the industry as mPRO (mobile

Scancell said that SCIB1 is a new DNA ImmunoBody vaccine being developed using its patented ImmunoBody technology for the treatment of melanoma. In addition, Scancell’s US partner Ichor

Akrimax Pharmaceuticals said that Mr Larimer has 20 years of combined management, sales, marketing and operations experience in the pharmaceutical industry. Most recently, he has served as senior

Upon issuance, the patent is expected to provide Vicor with patent protection for methods of using a peptide to treat infarctions, such as cardiac or cerebral infarctions. Vicor